Influence of family history on survival in patients with colon and rectal cancer. Issue 3 (March 2014)

• Record Type: Journal Article
• Authors: Lee, Seong Dae; Kim, Byung Chang; Han, Kyung Su; Hong, Chang Won; Sohn, Dae Kyung; Park, Ji Won; Park, Sung Chan; Kim, Sun Young; Baek, Ji‐Yeon; Chang, Hee Jin; Kim, Dae Yong; Oh, Jae Hwan
• Is Part Of: Journal of digestive diseases. Volume 15:Issue 3(2014:Mar.)
• Page Start: 108
• Page End: 115
• Publication Date: 2014-03
• Subjects: Digestive organs -- Diseases -- Periodicals; Gastroenterology -- Periodicals; 616.3
• DOI: 10.1111/1751-2980.12120
• Languages: English
• ISSNs: 1751-2972

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="cdd12120-sec-0001" sec-type="section"> <title>Objective</title> <p>We aimed to investigate the association between a family history (FH) of colorectal cancer (CRC) and cancer recurrence and survival in patients with stage III CRC.</p> </sec> <sec id="cdd12120-sec-0002" sec-type="section"> <title>Methods</title> <p>From April 2001 to December 2007, 1102 patients with stage III CRC were enrolled and their data including FH, clinicopathological characteristics of the tumor were retrospectively analyzed.</p> </sec> <sec id="cdd12120-sec-0003" sec-type="section"> <title>Results</title> <p>Of 971 patients that were finally enrolled, 63 (6.5%) reported CRC in at least one first‐degree relative. Death occurred in 12.7% of the CRC patients with an FH and 21.8% in those without an FH. A multivariate analysis showed that patients with an FH of CRC, compared with those without FH, had an adjusted hazard ratios (HR) of 0.674 (<italic>P</italic> = 0.281) for overall survival (OS) and 0.672 (<italic>P</italic> = 0.220) for disease‐free survival (DFS). However, the location of tumor, preoperative carcinoembryonic antigen (CEA) level, tumor invasion (T) stage and lymph node (N) metastasis significantly affected OS and DFS. Furthermore, whereas the FH of CRC patients was associated with a favorable prognosis in stage III colon cancer (HR 0.224, <italic>P</italic> = 0.040) but not in rectal cancer (HR 1.225, <italic>P</italic> = 0.640).</p> </sec> <sec id="cdd12120-sec-0004" sec-type="section"> <title>Conclusions</title> <p>In patients with stage III CRC, tumor location (especially in the rectum), a high preoperative CEA level and advanced T and N stages indicate a poor prognosis. However, in stage III colon cancer FH is associated with improved survival.</p> </sec> </abstract>